Viant Medical (PRIVATE.VIANTMED)

Overall impact
B (67)

Commentary

Viant Medical is a strong overall performer. With a 'B' rating of 66.8 for overall impact (76th percentile compared to all companies), Viant Medical ranks 96th out of 198 industry peers, behind Restoration Robotics, Corindus Vascular Robotics, Modular Medical and 92 others, and ahead of Medtronic, Axonics Modulation Technologies, Star Equity Holdings and 99 others. On top material causes for Viant Medical's industry (Health Care Equipment & Supplies), Viant Medical performs well in Child and Maternal Health (95.0 score), Child and Maternal Health (95.0), Disease Eradication (88.5) and 18 other causes where it received an 'A' score and performs poorly in Humane Treatment of Animals (38.5 score), Humane Treatment of Animals (38.5), Reduced Green House Gas Emissions (33.1) and 7 other causes where it received a 'D' or 'F' score.
Impact
Cause PRIVATE.VIANTMED
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company

Viant Medical

Employees
6,000
Sector
Materials
Industry
Chemicals
Sub-industry
Diversified Chemicals
SASB industry
Medical Equipment & Supplies
Headquarters
#<Country/State:0x00007f038057a780>, United States
Share classes
PRIVATE.VIANTMED
Description
Provider of design and manufacturing services intended to support original equipment manufacturers (OEMs) in the medical device industry. The company offers a broad range of services including engineering, manufacturing, assembly, packaging and sterilization of diagnostic, orthopedic, surgical and other medical products across surgical technologies, orthopedics, cardiac and interventional, bioelectronics, drug delivery, diagnostics and patient care markets, helping clients to expand their product offering, optimize supply chain and improve quality while managing costs on a global scale.
Material causes
Ethos considers the following causes material for Viant Medical, based on its industry sub-industry Diversified Chemicals. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.